Alfred Mann to invest in local factory

Construction of the factory will take two to three years, and it will employ several hundred workers when completed, a figure Mann intends to increase to several thousand.

By MATTHEW KRIEGER
October 16, 2007 08:30

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

US investor Alfred Mann said Monday he will invest some $250 million to construct a factory that will produce insulin inhalers developed by a subsidiary of medical equipment giant MannKind Corp. The factory is slated to be built in either the Gush Segev industrial park or in Netanya. Construction of the factory will take two to three years, and it will employ several hundred workers when completed, a figure Mann intends to increase to several thousand. MannKind's insulin inhaler is undergoing final trials for US Food & Drug Administration (FDA) approval.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS